O
GILD icon

OppenheimerFunds’s Gilead Sciences GILD Stock Holding History

OppenheimerFunds’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$244M Sell
3,756,356
-2,498,109
-40% -$166M 0.3% 85
2018
Q4 		$391M Sell
6,254,465
-949,880
-13% -$66.4M 0.56% 41
2018
Q3 		$556M Buy
7,204,345
+165,958
+2% +$12.5M 0.65% 28
2018
Q2 		$499M Buy
7,038,387
+22,916
+0.3% +$1.62M 0.59% 31
2018
Q1 		$529M Buy
7,015,471
+57,598
+0.8% +$4.58M 0.66% 27
2017
Q4 		$498M Sell
6,957,873
-892,111
-11% -$67.7M 0.6% 29
2017
Q3 		$636M Buy
7,849,984
+18,294
+0.2% +$1.4M 0.78% 16
2017
Q2 		$554M Buy
7,831,690
+3,690,983
+89% +$246M 0.68% 16
2017
Q1 		$281M Buy
4,140,707
+626,840
+18% +$44.1M 0.34% 83
2016
Q4 		$252M Buy
3,513,867
+150,037
+4% +$11.2M 0.32% 94
2016
Q3 		$266M Buy
3,363,830
+319,119
+10% +$25.9M 0.33% 80
2016
Q2 		$254M Buy
3,044,711
+131,337
+5% +$11.7M 0.33% 82
2016
Q1 		$268M Sell
2,913,374
-6,358,098
-69% -$573M 0.35% 71
2015
Q4 		$938M Buy
9,271,472
+1,162,940
+14% +$121M 1.19% 7
2015
Q3 		$796M Buy
8,108,532
+121,857
+2% +$13.5M 1.08% 8
2015
Q2 		$935M Buy
7,986,675
+20,011
+0.3% +$2.19M 1.07% 12
2015
Q1 		$782M Sell
7,966,664
-95,156
-1% -$9.66M 0.87% 13
2014
Q4 		$760M Sell
8,061,820
-1,296,832
-14% -$134M 0.85% 12
2014
Q3 		$996M Sell
9,358,652
-870,360
-9% -$85.2M 1.1% 8
2014
Q2 		$848M Buy
10,229,012
+198,698
+2% +$15.5M 0.94% 10
2014
Q1 		$711M Buy
10,030,314
+2,266,858
+29% +$178M 0.84% 14
2013
Q4 		$583M Buy
7,763,456
+306,246
+4% +$21.3M 0.71% 18
2013
Q3 		$469M Buy
7,457,210
+1,668,776
+29% +$99.7M 0.62% 24
2013
Q2 		$296M Buy
+5,788,434
New +$302M 0.43% 49

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OppenheimerFunds's GILD Position: Q1 2019 in Review

OppenheimerFunds reduced its Gilead Sciences (GILD) stake by 40% in Q1 2019, selling an estimated $166M and leaving 3,756,356 shares worth $244M. The position accounts for 0.3% of the portfolio, ranked #85.

OppenheimerFunds first reported a position in GILD in Q2 2013 and has held it in 24 quarters since. The position peaked at $996M in Q3 2014. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • OppenheimerFunds held 3,756,356 shares of Gilead Sciences worth $244M as of Q1 2019.
  • OppenheimerFunds sold 2,498,109 Gilead Sciences shares in Q1 2019, an estimated $166M.
  • Gilead Sciences made up 0.3% of OppenheimerFunds's portfolio in Q1 2019, its #85 holding.
  • OppenheimerFunds first reported a position in Gilead Sciences in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Gilead Sciences position peaked at $996M in Q3 2014.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.